Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry

NCT04545333 is registered in ClinicalTrials.gov with Adaptive Biotechnologies as lead sponsor.

NCT NCT04545333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04545333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Observational Study Using clonoSEQ® Next Generation Sequencing in Hematologic Malignancies: The 'Watch' Registry
Lead sponsor
Adaptive Biotechnologies
Phase
Observational
Overall status
Terminated
Start date
October 13, 2020
Completion date
October 1, 2023
Enrollment
465 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia, adult b-cell, chronic lymphocytic leukemia, multiple myeloma, non-hodgkin lymphoma